Financhill
Sell
22

CDLX Quote, Financials, Valuation and Earnings

Last price:
$3.56
Seasonality move :
-16.43%
Day range:
$3.47 - $3.62
52-week range:
$2.76 - $20.52
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.55x
P/B ratio:
2.60x
Volume:
493.8K
Avg. volume:
898.9K
1-year change:
-45.48%
Market cap:
$180.9M
Revenue:
$309.2M
EPS (TTM):
-$6.29

Analysts' Opinion

  • Consensus Rating
    Cardlytics has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $4.40, Cardlytics has an estimated upside of 23.6% from its current price of $3.56.
  • Price Target Downside
    According to analysts, the lowest downside price target is $4.00 representing 100% downside risk from its current price of $3.56.

Fair Value

  • According to the consensus of 5 analysts, Cardlytics has 23.6% upside to fair value with a price target of $4.40 per share.

CDLX vs. S&P 500

  • Over the past 5 trading days, Cardlytics has overperformed the S&P 500 by 3.19% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Cardlytics does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Cardlytics revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Cardlytics reported revenues of $67.1M.

Earnings Growth

  • Cardlytics has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Cardlytics reported earnings per share of -$2.90.
Enterprise value:
327.2M
EV / Invested capital:
--
Price / LTM sales:
0.55x
EV / EBIT:
--
EV / Revenue:
1.11x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-11.93x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$127.7M
Return On Assets:
-50.62%
Net Income Margin (TTM):
-93.55%
Return On Equity:
-163.62%
Return On Invested Capital:
-67.37%
Operating Margin:
-25.13%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $302.5M $302.5M $293.5M $79M $67.1M
Gross Profit $113.7M $124.3M $127.7M $35.8M $28.6M
Operating Income -$118.4M -$76.5M -$63.1M -$12.3M -$16.9M
EBITDA -$74.9M -$374.7M -$238M -$15.6M -$135.3M
Diluted EPS -$3.51 -$12.22 -$6.29 -$0.63 -$2.90
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $353.9M $335.5M $249.1M $205.6M $183.3M
Total Assets $389.4M $1.2B $1.1B $634.9M $399.4M
Current Liabilities $58.3M $274.5M $254.9M $179.5M $155.9M
Total Liabilities $239.1M $536M $485.8M $409.6M $329.7M
Total Equity $150.4M $688.6M $580.5M $225.3M $69.7M
Total Debt $171.5M $181.7M $225.7M $257.1M $213.2M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$41.4M -$16.2M -$8.9M $1.2M $1.4M
Cash From Investing -$16M -$11.8M -$16M -$3.1M -$5.3M
Cash From Financing -$39.6M -$20.3M $1.7M $21K -$388K
Free Cash Flow -$55.1M -$28.1M -$27.4M -$2M -$3.9M
CDLX
Sector
Market Cap
$180.9M
$100.5M
Price % of 52-Week High
17.35%
68.75%
Dividend Yield
0%
0%
Shareholder Yield
-24.79%
3.33%
1-Year Price Total Return
-45.48%
-11.93%
Beta (5-Year)
1.540
0.704
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $3.37
200-day SMA
Sell
Level $5.59
Bollinger Bands (100)
Sell
Level 3.22 - 4.06
Chaikin Money Flow
Buy
Level 30.7M
20-day SMA
Buy
Level $3.36
Relative Strength Index (RSI14)
Buy
Level 55.52
ADX Line
Buy
Level 14.94
Williams %R
Neutral
Level -32.6923
50-day SMA
Buy
Level $3.52
MACD (12, 26)
Sell
Level -0.02
25-day Aroon Oscillator
Buy
Level 20
On Balance Volume
Neutral
Level 61.4M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-2.2999)
Sell
CA Score (Annual)
Level (-2.2281)
Buy
Beneish M-Score (Annual)
Level (-3.5889)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (4.6459)
Buy
Piotroski F Score (Annual)
Level (6)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Stock Forecast FAQ

In the current month, CDLX has received 0 Buy ratings 5 Hold ratings, and 0 Sell ratings. The CDLX average analyst price target in the past 3 months is $4.40.

  • Where Will Cardlytics Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Cardlytics share price will rise to $4.40 per share over the next 12 months.

  • What Do Analysts Say About Cardlytics?

    Analysts are divided on their view about Cardlytics share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cardlytics is a Sell and believe this share price will drop from its current level to $4.00.

  • What Is Cardlytics's Price Target?

    The price target for Cardlytics over the next 1-year time period is forecast to be $4.40 according to 5 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.

  • Is CDLX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Cardlytics is a Hold. 5 of 5 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of CDLX?

    You can purchase shares of Cardlytics via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cardlytics shares.

  • What Is The Cardlytics Share Price Today?

    Cardlytics was last trading at $3.56 per share. This represents the most recent stock quote for Cardlytics. Yesterday, Cardlytics closed at $3.56 per share.

  • How To Buy Cardlytics Stock Online?

    In order to purchase Cardlytics stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Tesla Stock Falling?
Why Is Tesla Stock Falling?

Tesla stock reached an all-time high of $479.86 on December…

Is DoorDash a Buy, Sell or Hold?
Is DoorDash a Buy, Sell or Hold?

Gig economy food delivery service DoorDash (NASDAQ:DASH) has been running…

Is Clorox’s Dividend Worth It?
Is Clorox’s Dividend Worth It?

Clorox (NYSE:CLX) is the parent company of some of the…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 116x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $3T
P/E Ratio: 35x

Alerts

Buy
87
PCOR alert for Feb 15

Procore Technologies [PCOR] is up 16.3% over the past day.

Buy
54
DKNG alert for Feb 15

DraftKings [DKNG] is up 15.24% over the past day.

Sell
30
TWLO alert for Feb 15

Twilio [TWLO] is down 15.01% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock